PDL BioPharma, Inc. Non-operating Interest Expenses

Non-operating Interest Expenses of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Interest Expenses growth rates and interactive chart. Interest expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from interest expenses.


Highlights and Quick Summary

  • Non-operating Interest Expenses for the quarter ending June 29, 2020 was $312 Thousand (a -34.18% decrease compared to previous quarter)
  • Year-over-year quarterly Non-operating Interest Expenses decreased by -89.64%
  • Annual Non-operating Interest Expenses for 2019 was $11.4 Million (a -6.19% decrease from previous year)
  • Annual Non-operating Interest Expenses for 2018 was $12.2 Million (a -39.88% decrease from previous year)
  • Annual Non-operating Interest Expenses for 2017 was $20.2 Million (a 10.7% increase from previous year)
  • Twelve month Non-operating Interest Expenses ending June 29, 2020 was $6.25 Million (a -29.95% decrease compared to previous quarter)
  • Twelve month trailing Non-operating Interest Expenses decreased by -47.23% year-over-year
Trailing Non-operating Interest Expenses for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$6.25 Million $8.92 Million $11.4 Million $11.8 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Interest Expenses of PDL BioPharma, Inc.

Most recent Non-operating Interest Expensesof PDLI including historical data for past 10 years.

Interactive Chart of Non-operating Interest Expenses of PDL BioPharma, Inc.

PDL BioPharma, Inc. Non-operating Interest Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.31 $0.47
2019 $2.45 $3.01 $2.98 $2.96 $11.4
2018 $2.9 $2.87 $2.81 $3.59 $12.16
2017 $5.14 $5.1 $5.02 $4.97 $20.22
2016 $4.74 $4.51 $4.46 $4.55 $18.27
2015 $5.35 $5.9 $7.2 $8.61 $27.06
2014 $9.44 $9.39 $9.86 $10.53 $39.21
2013 $6.7 $6.12 $6.05 $6.0 $24.87
2012 $5.95 $6.51 $7.87 $8.7 $29.04
2011 $8.16 $9.01 $9.78 $9.15 $36.1
2010 $9.51 $9.93 $11.56 $43.53

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.